Delivery Order SPE2DB22D1017-SPE2DB24FF9VM

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to supply Dupixent 300 mg/2 ml pen injectors. The $3,304.72 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pen injectors. The $66,553.78 firm fixed-price delivery order is not set aside for any specific business category. It is part of a larger Indefinite Delivery Contract valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to procure a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $57,326.42, is for the delivery of Dupixent 300 mg/2 ml pen injections. It is a firm fixed-price delivery order contract with a completion date of December 13, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a 300 mg/2 mL Dupixent injection pen. The $9,763.71 delivery order is a firm fixed-price contract that is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a range of medical commodities to support military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,406.15 Firm Fixed Price Delivery Order contract covers the supply of Dupixent 300 mg/2 ml pen injectors, with a period of performance through September 18, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award to AmerisourceBergen Drug Corp for the delivery of Dupixent 300 mg/2 ml pen injectors, valued at $7,849.28. The contract was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor on this award. The contract is associated with a larger...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a 300 mg/2 mL Dupixent pen for $5,843.08. The contract is a delivery order with a firm fixed price and a completion date of September 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply Dupixent 300 mg/2 ml injection pens. The delivery order, valued at $36,195.41, is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, with a ceiling value of up to $999,999,999, for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,304.72, is for the supply of Dupixent 300 mg/2 ml pen injectors. The order has a period of performance through September 2024 and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999, for providing a...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml pens. The $7,743.22 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF9VM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Dupixent 300 mg/2 ml pen injectors. The contract, valued at $6,035.96, is a firm-fixed-price delivery order with a completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 9/17/24, 9:15 AM